Cardeas Pharma develops a novel antibiotic formulation of two drugs with synergistic activity.
Business Model:
Revenue: $7.5M
Employees: 11-50
Address: 2025 1st Ave
City: Seattle
State: WA
Zip: 98121
Country: US
Cardeas Pharma develops a novel antibiotic formulation of two drugs with synergistic activity.
Contact Phone:
+12069731026
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 4/2015 | Series B | 6 | $37.5M |
Avalon Ventures Delphi Ventures Devon Park BioVentures H.I.G. BioHealth Partners Novo Ventures Washington Research Foundation Avalon Ventures Delphi Ventures Devon Park BioVentures H.I.G. BioHealth Partners Novo Ventures Washington Research Foundation |
5/2013 | Series B | $34M | 5/2013 | Series B | $37.5M |
H.I.G. BioVentures, LLC Novo A/S Avalon Ventures Devon Park Bioventures Delphi Ventures |
6/2012 | Series A | 3 | $8.5M |
Avalon Ventures Devon Park BioVentures Novo Ventures Avalon Ventures Devon Park BioVentures Novo Ventures |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|